Ariel Kredentser
Papers
1
Total Citations
2
H-Index
1
About
Ariel Kredentser is a rising researcher in the field of gynecologic oncology, with a focused interest in optimizing perioperative care for patients undergoing surgery for gynecologic malignancies. Her most notable contribution to date is a 2025 study on the addition of metronidazole to standard perioperative antibiotic prophylaxis at the time of hysterectomy. This work addresses a critical gap in infection prevention strategies, aiming to reduce postoperative complications in a high-risk surgical population. While her citation count is still emerging—reflecting the recent publication of her key paper—the study has already garnered attention within the surgical oncology community for its potential to improve patient outcomes through a simple, cost-effective intervention. Kredentser’s research underscores the importance of evidence-based refinements to established protocols, and her work is poised to influence clinical guidelines as it gains further recognition. As an early-career investigator, she demonstrates a commitment to translational research that directly impacts surgical safety and recovery in gynecologic cancer care.
Research Focus
Key Achievements
Top Papers
- 1